enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. AbbVie - Wikipedia

    en.wikipedia.org/wiki/AbbVie

    AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue . In 2023, the company's seat in Forbes Global 2000 was 74, [ 2 ] and rank 89 on the 2024 list. [ 3 ]

  3. Cerevel Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Cerevel_Therapeutics

    Cerevel Therapeutics Holdings, Inc. is an American biotechnology and pharmaceuticals company based in Cambridge, Massachusetts, focused on the development of novel therapies for mental and neurological illnesses.

  4. ImmunoGen - Wikipedia

    en.wikipedia.org/wiki/ImmunoGen

    ImmunoGen was founded in 1981 and was headquartered in Waltham, Massachusetts. [ 2 ] An ImmunoGen ADC contains a manufactured antibody that binds to a target found on cancer cells, with one of the company's potent cell-killing agents attached as a "payload".

  5. Drugmaker AbbVie to spend over $10B on ImmunoGen to ... - AOL

    www.aol.com/news/pharmaceutical-company-abbvie...

    Shares of Waltham, Massachusetts.-based ImmunoGen Inc. soared more than 80% to top $29 in mid-morning trading Thursday. North Chicago, Illinois-based AbbVie Inc. stock was up 2% to $141.26 while ...

  6. Abbott Laboratories - Wikipedia

    en.wikipedia.org/wiki/Abbott_Laboratories

    Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States.The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.

  7. AbbVie terminates deal with I-Mab to develop cancer drug - AOL

    www.aol.com/news/abbvie-terminates-deal-mab...

    AbbVie's decision to scrap the deal comes after it pulled the plug on an early-stage study in August last year that was testing lemzoparlimab in combination with two other drugs for treating two ...

  8. Shire (pharmaceutical company) - Wikipedia

    en.wikipedia.org/wiki/Shire_(pharmaceutical_company)

    On 20 June 2014, Shire rejected a takeover attempt by AbbVie. AbbVie offered £46.11 per share (£27.3 billion or $46.5 billion in total). [30] On 8 July, the offer was increased to $51.5 billion. [31] On 18 July, it was announced that AbbVie would acquire Shire for $54.8 billion. [32]

  9. 2 Dividend Kings That Would Have Doubled Your Money in 5 Years

    www.aol.com/finance/2-dividend-kings-doubled...

    Pharmaceutical company AbbVie spun off from Abbott Laboratories back in 2013. And if you include its time when it was part of the broader healthcare company, ...